Genoskin
FranceEntry
2025
Hold
1yr
Status
Active
Who owns Genoskin?
Genoskin is a French Biotech company, currently owned by Grand Sud-Ouest Capital since 2025 and 2 other investors.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Ownership history
3 ownership periods · co-invest detected
Active
Co-invest · 3 holders · 2024 · present
Finorpa GestionActive
2024 · present(2yr) · Captech Sante · 2022 · Life Sciences VC
OCCTEActive
2025 · present(1yr) · OCCIDEV IMPACTS · 2023 · Impact
Grand Sud-Ouest CapitalActive
2025 · present(1yr) · GSO Innovation · 2018 · Growth
More from OCCIDEV IMPACTS
Other portfolio companies in the same fund.
More OCCTE portfolio companies
From the same investor, across funds.
More PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns Genoskin?
Genoskin is currently owned by Grand Sud-Ouest Capital, OCCTE and 1 other, through OCCIDEV IMPACTS, since 2025.
When did Grand Sud-Ouest Capital and 2 others acquire Genoskin?
Grand Sud-Ouest Capital and 2 others acquired Genoskin in 2025.
Who has owned Genoskin over time?
Genoskin has been through 3 private-equity ownership periods: Finorpa Gestion · via Captech Sante · since 2024; Grand Sud-Ouest Capital · via GSO Innovation · since 2025; OCCTE · via OCCIDEV IMPACTS · since 2025.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue